Heidi Shupe has a myriad of medals proudly displayed in her home. But 20 years ago, her life looked a lot different.

In January 2023, the Brukinsa, a next-generation BTK inhibitor, received FDA approval for chronic lymphocytic leukemia (CLL).

Berry softball coach Darrell Thomas leads team into North Regional next week while undergoing chemotherapy treatments.

Q1 2025 earnings reveal Adaptive Biotechnologies' 34% MRD revenue growth, improved margins, and raised guidance.

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...

A new independent academic study examining a form of blood cancer among those who served at Malmstrom Air Force Base, Montana ...

Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat lymphomas ...

The four anti-CD20 drugs used in the U.S. to treat relapsing MS -- ocrelizumab, ofatumumab, and ublituximab (Briumvi; ...

High-dose chemotherapy and HSCT can provide long-term benefits in patients with MCL, a retrospective study suggests.

Researchers sought to assess the access to CAR-T therapy for patients within community-based and transplant cell therapy networks.

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that March ...

China’s NMPA has approved InnoCare Pharma’s orelabrutinib for use as a first-line treatment for CLL and small lymphocytic ...